Good samaritan protections - liability.

Checkout our iOS App for a better way to browser and research.

(1) The following individuals and entities are immune from criminal liability and from suit in any civil action brought by any person for injuries or related damages that result from an act or omission taken pursuant to this article:

  1. An authorized entity that possesses and makes available epinephrine auto-injectors oran EPAS and the entity's employees, agents, and other individuals;

  2. An authorized entity that does not possess or make available epinephrine autoinjectors or an EPAS and the entity's employees, agents, and other individuals;

  3. An individual or entity that conducts an anaphylaxis training program;

  4. An individual who prescribes or dispenses an epinephrine auto-injector;

  5. An individual who administers or provides an epinephrine auto-injector;

  6. A medical professional who consults the user of an EPAS and makes the epinephrineauto-injectors stored in the EPAS available to the user; or (g) An individual who uses an EPAS.

  1. Immunity under subsection (1) of this section does not apply to acts or omissions thatare grossly negligent or willful and wanton.

  2. This section does not eliminate, limit, or reduce any other immunity or defense thatmay be available under state law, including the protections set forth in section 13-21-108, C.R.S. Providing or administering an epinephrine auto-injector by an entity or individual is deemed emergency care or emergency assistance for purposes of section 13-21-108, C.R.S.

  3. An authorized entity located in this state that provides or administers an epinephrineauto-injector outside of this state is not liable for any resulting injuries or related damages if the authorized entity:

  1. Would not be liable for the injuries or related damages if the epinephrine autoinjector had been provided or administered in this state; or

  2. Is not liable for injuries or related damages under the law of the state where theauthorized entity provided or administered the epinephrine auto-injector.

Source: L. 2015: Entire article added, (HB 15-1232), ch. 191, p. 631, § 1, effective May 14.


Download our app to see the most-to-date content.